Exicure, Inc.XCURNASDAQ

52-Week Range3-16

3.10Current 4.4915.91

Want to monitor XCUR?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

exicure, formerly aurasense therapeutics, is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

David Giljohann

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Here's Why Jacobs Solutions (J) is a Strong Growth Stock

Why MasterCard (MA) is a Top Growth Stock for the Long-Term

Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term

MasTec (MTZ) is a Top-Ranked Growth Stock: Should You Buy?

Here's Why Goldman Sachs (GS) is a Strong Growth Stock

Why PBF Energy (PBF) is a Top Growth Stock for the Long-Term

Here's Why Palomar (PLMR) is a Strong Growth Stock

Transocean (RIG) is a Top-Ranked Growth Stock: Should You Buy?

Here's Why Valero Energy (VLO) is a Strong Growth Stock

Why CrowdStrike Holdings (CRWD) is a Top Growth Stock for the Long-Term

Why Myriad Genetics (MYGN) is a Top Growth Stock for the Long-Term

Why Micron's stock is sliding despite Nvidia-like earnings performance

Intuitive Machines under pressure after fourth quarter earnings miss

Five Below tops estimates with double-digit comps, raises FY26 outlook

FIBRA Prologis Announces an Ordinary Certificate Holders Meeting

Buy 3 Stocks That Announced Dividend Hikes Amid Geopolitical Tensions

Bank of America's Digitization Initiatives Unlocking Revenue Growth

Is GIS' Portfolio Reshaping Strategy Key to Long-Term Growth?

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Is Adecoagro (AGRO) Outperforming Other Consumer Staples Stocks This Year?

About